IN THE NEWS
All the best for 2024 !
Thérapies géniques, l’espoir fait revivre.
ART-TG is a partner of the IRIS network of excellence (RHU) aiming to develop new generations of gene therapies for severe immune deficiencies. In this consortium, ART-TG will bring its expertise on the quality control of genetically modified cells.